Overview and Scope
A lentiviral vector refers to a type of viral vector derived from lentiviruses, a subgroup of retroviruses known for their ability to integrate genetic material into the DNA of the host cell’s genome. These vectors are commonly used in molecular biology and gene therapy applications to deliver genetic material into target cells for various purposes, including gene expression, gene silencing, or genetic modification.
Sizing and Forecast
The lentiviral vector market size has grown rapidly in recent years. It will grow from $12.50 billion in 2023 to $14.37 billion in 2024 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to prevalence of genetic disorders, gene delivery demand, biotech and pharma expansion, clinical trial investment, regulatory approvals.
The lentiviral vector market size is expected to see rapid growth in the next few years. It will grow to $25.50 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to personalized medicine growth, gene editing innovations, rare disease therapy demand, lentiviral vector adoption, genomic medicine funding, manufacturing scalability focus. Major trends in the forecast period include expansion of research and development, integration in CAR-T cell therapy, development of next-generation vectors, adoption in vaccine development, development of production technologies.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/lentiviral-vector-global-market-report
Segmentation & Regional Insights
The lentiviral vector market covered in this report is segmented –
1) By Product Type: Kits, Reagents And Consumables
2) By Indication: Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications
3) By End User: Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes
North America was the largest region in the lentiviral vector market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14742&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of chronic diseases is expected to propel the lentiviral vectors market going forward. Chronic diseases refer to long-term medical conditions that typically progress slowly over time and often persist for years or even a lifetime. The prevalence of chronic diseases is increasing due to aging populations, unhealthy lifestyles, urbanization, and environmental factors. Lentiviral vectors offer versatile and efficient tools for developing vaccines and treatment strategies for chronic diseases, addressing unmet medical needs, and improving patient outcomes. For instance, in January 2023, according to the report published by the National Library of Medicine, the US-based medical library, It is expected that there will be around 142.66 million people with at least one chronic illness by 2050, a 99.5% rise from 71.522 million in 2020. Therefore, the increasing prevalence of chronic diseases is driving the growth of the lentiviral vectors market.
Key Industry Players
Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag , Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi
The lentiviral vector market report table of contents includes:
1. Executive Summary
2. Lentiviral Vector Market Characteristics
3. Lentiviral Vector Market Trends And Strategies
4. Lentiviral Vector Market – Macro Economic Scenario
5. Global Lentiviral Vector Market Size and Growth
…
32. Global Lentiviral Vector Market Competitive Benchmarking
33. Global Lentiviral Vector Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Lentiviral Vector Market
35.Lentiviral Vector Market Future Outlook and Potential Analysi
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
